Advertisement
Organisation › Details
Pierre Fabre Translational Medicine Department (Toulouse, IRPF)
About Institut de Recherche Pierre Fabre (IRPF) Dedicated to the fight against cancer and specialized in targeted biotherapy research, the Pierre Fabre Immunology Center, located at Saint-Julien-en-Genevois (France), near Geneva, is focused on research into monoclonal antibodies for use in oncology and the production of biotechnological active substances. In 2014, Pierre Fabre’s Antibody Biotechnology Unit (UBA) acquired new premises dedicated to the production of antibodies conjugated to cytotoxic agents (Antibody-Drug Conjugates - ADC). The premises facilitate the coupling and purification of antibodies with highly active compounds. Pierre Fabre Translational Medicine Department was created in 2016 and is located in Toulouse (France). Its main remit is developing clinically viable patient selection options across all the R&D projects. In addition, the department has a sharp focus on the new target identification & validation via internal bioinformatics strengths combined with external partnerships network. *
Start | 2018-05-18 existent | |
Group | Pierre Fabre (Group) | |
Industry | pharmaceutical | |
Region | Toulouse | |
Country | France | |
City | n. a. Toulouse | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Pierre Fabre S.A.. (5/18/18). "Press Release: Pierre Fabre and Roche Extend Collaboration Agreement on Companion Diagnostic Development". Castres. | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Pierre Fabre (Group)
- [1] Pierre Fabre. (3/1/24). "Press Release: Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories". San Francisco, CA & Castres....
- [2] Pierre Fabre. (1/26/24). "Press Release: Eau Thermale Avène Hits a Billion Euros in Turnover, and Strengthens Its Medical Positioning". Toulouse....
- [3] Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres....
- [4] Scorpion Therapeutics, Inc.. (4/4/23). "Press Release: Scorpion Therapeutics and Pierre Fabre Announce Collaboration and License Agreement to Co-Develop and Commercialize STX-721 and STX-241 for Patients with EGFR Mutant Non-Small Cell Lung Cancer". Bost...
- [5] Urovant Sciences. (7/5/22). "Press Release: Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland". Basel &...
- [6] Ribonexus. (11/18/21). "Press Release: Aglaia Therapeutics Becomes Ribonexus and Signs Exclusive License Agreement with Pierre Fabre on Small Molecules Targeting eIF4A, an Innovative Target in Oncology". Villejuif & Castres....
- [7] Pierre Fabre S.A.. (10/7/21). "Press Release: Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre". Victoria, BC & Castres....
- [8] Atara Biotherapeutics, Inc.. (10/4/21). "Press Release: Atara Biotherapeutics and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel (Tab-cel)". South San Francisco, CA & Castres....
- [9] HypnoVR S.A.S.. (7/19/21). "Press Release: HypnoVR – the First Virtual Reality Medical Hypnosis Solution for Reducing Patient Anxiety During Dental Treatment"....
- [10] Puma Biotechnology, Inc.. (12/2/19). "Press Release: Puma Biotechnology Amends License Agreement with Pierre Fabre to Include Additional Countries". Berlin....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top